If You Invested in Seneca Biopharma Inc (SNCA)
See the SNCA overviewWhat $1,000 or $10,000 in SNCA Was Worth at Its Last Close
Real historical value by amount invested and how long before the last close| If you invested | 1 year before | 5 years before | 10 years before | Since Nov 1, 2019 |
|---|---|---|---|---|
| $1,000 | $2,147 +115% | — | — | $1,177 +18% |
| $10,000 | $21,469 +115% | — | — | $11,773 +18% |
Based on real historical closing prices adjusted for stock splits, without dividends, through 2021-04-27. Figures with dividends reinvest each cash dividend at the previous close less the dividend, before taxes. Past performance does not guarantee future results.
Custom Calculation
Choose your own date and amount for SNCA$1,000 Investment Over Time
SNCA vs S&P 500Year-by-Year Returns
SNCA annual performance| Year | Start Price | End Price | Annual Return | Cumulative |
|---|---|---|---|---|
| 2019Nov 1, 2019 to Dec 31, 2019 | $8.46 | $5.94 | -29.8% | -29.8% |
| 2020 | $5.94 | $5.28 | -11.1% | -37.6% |
| 2021Dec 31, 2020 to Apr 27, 2021 | $5.28 | $9.96 | +88.6% | +17.7% |
About Seneca Biopharma Inc
Frequently Asked Questions
Seneca Biopharma Inc investment returns
How much was $1,000 invested in Seneca Biopharma Inc worth at its last close?
If you invested $1,000 in Seneca Biopharma Inc (SNCA) 1 year before its last close, on 2020-04-27, your investment was worth $2,147 on 2021-04-27, a +114.7% price return without dividends, growing at a compounded rate of 114.8% per year (CAGR).
Has Seneca Biopharma Inc outperformed the S&P 500?
Comparison data requires at least 10 years of trading history. Use the calculator above to compare SNCA performance over available time periods.
What is Seneca Biopharma Inc's average annual return?
The compound annual growth rate (CAGR) of SNCA’s share price over the 1 year to Apr 27, 2021 is 114.8%, without dividends. Individual years vary a great deal, and SNCA’s best recent full year was 2020 (-11.1%) while the worst was 2020 (-11.1%).
For informational and educational purposes only, not investment advice.
